BRIEF published on 07/06/2026 at 07:05, 2 months 26 days ago ReproNovo Begins EU Phase 2 Trial for Embryo Implantation Treatment ReproNovo RPN-002 Embryo Implantation NORDIC Trial Assisted Reproductive Technology
BRIEF published on 07/06/2026 at 07:05, 2 months 26 days ago ReproNovo lance un essai clinique de phase 2 dans l'UE pour son traitement d'implantation d'embryons. ReproNovo RPN-002 Implantation D'embryons Essai Nordique Techniques De Procréation Assistée
PRESS RELEASE published on 07/06/2026 at 07:00, 2 months 26 days ago ReproNovo Announces First Participant Dosed In EU Phase 2 Trial Of RPN-002 Embryo Implantation ReproNovo doses first participant in EU Phase 2 trial of RPN-002 for embryo implantation, aiming to increase IVF success rates with oxytocin receptor antagonist ReproNovo RPN-002 Embryo Implantation EU Phase 2 Trial IVF Success
BRIEF published on 03/20/2026 at 13:05, 6 months 11 days ago ReproNovo Appoints Mark Altmeyer as Chairman of the Board Biopharmaceutical Fertility Leadership ReproNovo Mark Altmeyer
BRIEF published on 03/20/2026 at 13:05, 6 months 11 days ago ReproNovo nomme Mark Altmeyer président du conseil d'administration Biopharmaceutique Direction ReproNovo Mark Altmeyer Fécondité
PRESS RELEASE published on 03/20/2026 at 13:00, 6 months 11 days ago REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD ReproNovo appoints Mark Altmeyer as Chairman of the Board. Altmeyer brings 35+ years of biopharma leadership experience across multiple therapeutic areas Chairman Fertility Biopharma ReproNovo Mark Altmeyer
BRIEF published on 09/30/2025 at 07:05, 1 year ago ReproNovo Gains Approval for RPN-001 Clinical Trial in China Clinical Trial China Approval ReproNovo Reproductive Medicine RPN-001
BRIEF published on 09/30/2025 at 07:05, 1 year ago ReproNovo obtient l'approbation pour l'essai clinique RPN-001 en Chine Essai Clinique ReproNovo RPN-001 Approbation De La Chine Médecine De La Reproduction
PRESS RELEASE published on 09/30/2025 at 07:00, 1 year ago ReproNovo Announces Clinical Trial Approval Notice for RPN-001 in China ReproNovo receives approval for RPN-001 Phase 1 trial in China from NMPA, a key step in global development for male infertility treatment. Company expanding clinical programs in the U.S. and China China Male Infertility Clinical Trial ReproNovo RPN-001
BRIEF published on 07/01/2025 at 07:05, 1 year 3 months ago ReproNovo Initiates Phase 2 Trial for Male Infertility Drug in the U.S. Male Infertility Phase 2 Trial ReproNovo RPN-001 Low Testosterone
Published on 10/01/2026 at 08:02, 1 hour 40 minutes ago Southern Energy Announces Results of Annual Meeting and Board Changes
Published on 10/01/2026 at 01:21, 8 hours 21 minutes ago Revival Gold Announces Filing of Final Base Shelf Prospectus
Published on 10/01/2026 at 01:00, 8 hours 42 minutes ago Algo Grande Copper Secures Five-Year Surface Access Agreement With Ejido Palos Chinos at the Adelita Project
Published on 09/30/2026 at 23:30, 10 hours 12 minutes ago Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 13 hours 7 minutes ago Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 10/01/2026 at 09:38, 4 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 Notice of Annual General Meeting – FY27 LTI Grant
Published on 10/01/2026 at 09:25, 16 minutes ago centrotherm reports solid first-half results for 2026 in a challenging market environment
Published on 10/01/2026 at 09:10, 31 minutes ago COSRX Becomes the First K-Beauty Brand to Sponsor Maison Margiela at Paris Fashion Week
Published on 10/01/2026 at 09:05, 36 minutes ago FORCYD expands into Switzerland and appoints Bob Dillen as Partner to lead Swiss practice
Published on 10/01/2026 at 09:05, 36 minutes ago H.I.G. Capital Announces the Sale of Pinalli to Borletti Group
Published on 10/01/2026 at 08:30, 1 hour 12 minutes ago Eurazeo opens an office in Abu Dhabi, reinforcing its commitment to the Middle East
Published on 10/01/2026 at 08:30, 1 hour 12 minutes ago Cegedim Business Services dévoile Hospi-DM, sa nouvelle offre SaaS de traçabilité des dispositifs médicaux, lors des 36èmes Journées Euro-Pharmat
Published on 10/01/2026 at 08:30, 1 hour 12 minutes ago Eurazeo ouvre un bureau à Abu Dhabi et renforce son engagement au Moyen-Orient
Published on 10/01/2026 at 08:00, 1 hour 42 minutes ago CNP Assurances and Embracon complete their combination to create a leading consórcio player in Brazil
Published on 10/01/2026 at 08:00, 1 hour 42 minutes ago CNP Assurances et Embracon finalisent leur rapprochement pour former un acteur majeur du consórcio au Brésil
